Moreover, BDNF is positively regulated by the ER chaperon sigma-1 receptor (S1R), and studies have shown that fluvoxamine, a S1R agonist, ameliorates depression-like behaviors in DM-induced depression (Lenart et al., 2016). Here, TMBIM4 is linked to major depressive disorder.